#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cognitive dysfunction in patients with systemic lupus erythemathosus with or without antiphospholipid antibodies


Authors: Ľ. Cibičková 1;  T. Soukup 1;  E. Čermáková 2;  P. Bradna 1;  Z. Hrnčíř 1
Authors‘ workplace: II. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc. 1;  Ústav lékařské biofyziky Lékařské fakulty UK Hradec Králové, přednosta doc. Ing. Josef Hanuš, CSc. 2
Published in: Vnitř Lék 2007; 53(3): 242-245
Category: Original Contributions

Overview

Introduciton:
Impairment of cognitive functions is one of the neuropsychiatric symptoms of systemic lupus erythemathosus (SLE), the association of which with secondary antiphospholipid syndrome is often mentioned in the literature on the subject. Ethiology has not yet been fully clarified.

Patients and methods:
The aim of the study was to compare the „mini-mental state examination“ (MMSE) outcomes in SLE patients with and without antiphospholipid antibodies (APA).

Results:
Probands producing APA presented with significantly worse results in MMSE when compared to patients without these antibodies. There was no difference between patients with antisphospholipid syndrome and those with APA only.

Discussion and conclusion:
Our study supports the notion that association of SLE with APA (not only with antiphospholipid syndrome) aggravates the deterioration of cognitive functions. MMSE test should not be omitted in the follow-up of SLE patients.

Key words:
systemic lupus erythematosus – antiphospholipid antibodies – cognitive functions – mini-mental state examination


Sources

1. Hochberg M Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1734.

2. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.

3. Asherson RA, Mercey D, Philips G et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1987; 46: 605-611.

4. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.

5. Asherson RA, Khamashta MA, Gil A et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391-399.

6. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 11: 1271-1277.

7. Folstein MF, Folstein SE, McHugn PR „Mini-Mental State“: a practical Metod for grading the cognitive state of patients for the clinican. J Psychiatr Res 1975; 12: 189-198.

8. Anthony JC, LeResche L, Niaz U et al. Limits of the „Mini-Mental State“ as a screening test for dementia a and delirium among hospital patients. Psychol Med 1982; 12: 397-408.

9. Peterová V, Faber J, Dostál C et al. EEG nálezy u nemocných se systémovým lupus erythematosus. Sborník lékařský 1999; 4: 309-313.

10. Lee SI, Jeon HS, Yoo WH. Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction. Rheumatol Int 2004; 24: 305-308.

11. Jirák R, Koukolník F. Demence - Neurobiologie, klinický obraz, terapie. 1. ed. Praha: Galén 2004: 85.

12. Sastre-Garriga J, Montalban Y. APS and the brain. Lupus 2003; 12: 877-882.

13. Harris EN, Gharavi AE, Asherson RA et al. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 47-51.

14. Maeshima E, Yamada Y, Yukawa S et al. Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus. Intern Med 1992; 31: 1169-1174.

15. Asherson RA, Lubbe WF. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. J Rheumatol 1988; 15: 539-543.

16. Soltesz P, Veres K, Lakos G et al. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospektive study of 637 patients. Lupus 2003; 12: 302-307.

17. Caronti B, Calderaro C, Alessandri C et al. Serum anti-β2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 1998; 11: 425-429.

18. Chapman J, Cohen-Armon M, Schoenfeld Y et al. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8: 127-133.

19. Chapman J, Abu-Katash M, Inzelbarg R et al. Prevalence and clinical features of dementia associated with the antifosfolipid syndrome and circulating anticoagulants. J Neurol Sci 2002; 203-204: 81-84.

20. Fukui T, Kawamura M, Hasegawa Y et al. Multiple cognitive impairments associated with systemic lupus erythematosus and antiphospholipid antibody syndrome: a form of progressive vascular dementia? European Neurology 2000; 43: 115-116.

21. Brey RL, Holliday RL, Sakland AR et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002; 58: 1214-1220.

22. Glanz BI, Schur PH, Lew RA et al. Lateralized cognitive dysfunction in patients with systemic lupus erythematosus. Lupus 2005; 14: 896-902.

23. Erkan D, Yazici Y, Sobel R et al. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 2000; 27: 2817-2821.

24. Mosek A, Yust I, Treves TA et al. Dementia and antiphospholipid antibodies. Dement Geriat Cogn Dis 2000; 11: 36-38.

25. Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer´s disease. Neuroepidemiology 2004; 23: 94-98.

26. Rockwood K, Kirkland S, Hogan DB et al. Use of lipid-lowering agents, indication bias, and the risk of dementi in community-dwelling elderly people. Arch Neurol 2002; 59: 223-227.

Labels
Diabetology Endocrinology Internal medicine
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#